molecules of the month


dihydroorotate dehydrogenase inhibitor

in Ph. I for RR-lymphoma

from opt. of literature molecule

Mol. Cancer Ther., Oct. 20, 2020

Agios Pharmaceuticals, Cambridge, MA

Structure of AG-636
1 min read

AG-636 (Agios Pharmaceuticals dihydroorotate dehydrogenase (DHODH) inhibitor clinical candidate)

request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.

already a member? log in: